These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 20837928

  • 1. Preoperative atorvastatin treatment in CABG patients rapidly improves vein graft redox state by inhibition of Rac1 and NADPH-oxidase activity.
    Antoniades C, Bakogiannis C, Tousoulis D, Reilly S, Zhang MH, Paschalis A, Antonopoulos AS, Demosthenous M, Miliou A, Psarros C, Marinou K, Sfyras N, Economopoulos G, Casadei B, Channon KM, Stefanadis C.
    Circulation; 2010 Sep 14; 122(11 Suppl):S66-73. PubMed ID: 20837928
    [Abstract] [Full Text] [Related]

  • 2. Treatment with ezetimibe plus low-dose atorvastatin compared with higher-dose atorvastatin alone: is sufficient cholesterol-lowering enough to inhibit platelets?
    Piorkowski M, Fischer S, Stellbaum C, Jaster M, Martus P, Morguet AJ, Schultheiss HP, Rauch U.
    J Am Coll Cardiol; 2007 Mar 13; 49(10):1035-42. PubMed ID: 17349882
    [Abstract] [Full Text] [Related]

  • 3. Rapid, direct effects of statin treatment on arterial redox state and nitric oxide bioavailability in human atherosclerosis via tetrahydrobiopterin-mediated endothelial nitric oxide synthase coupling.
    Antoniades C, Bakogiannis C, Leeson P, Guzik TJ, Zhang MH, Tousoulis D, Antonopoulos AS, Demosthenous M, Marinou K, Hale A, Paschalis A, Psarros C, Triantafyllou C, Bendall J, Casadei B, Stefanadis C, Channon KM.
    Circulation; 2011 Jul 19; 124(3):335-45. PubMed ID: 21730307
    [Abstract] [Full Text] [Related]

  • 4. Atorvastatin has an important acute anti-inflammatory effect in patients with acute coronary syndrome: results of a randomized, double-blind, placebo-controlled study.
    Macin SM, Perna ER, Farías EF, Franciosi V, Cialzeta JR, Brizuela M, Medina F, Tajer C, Doval H, Badaracco R.
    Am Heart J; 2005 Mar 19; 149(3):451-7. PubMed ID: 15864233
    [Abstract] [Full Text] [Related]

  • 5. Myocardial redox state predicts in-hospital clinical outcome after cardiac surgery effects of short-term pre-operative statin treatment.
    Antoniades C, Demosthenous M, Reilly S, Margaritis M, Zhang MH, Antonopoulos A, Marinou K, Nahar K, Jayaram R, Tousoulis D, Bakogiannis C, Sayeed R, Triantafyllou C, Koumallos N, Psarros C, Miliou A, Stefanadis C, Channon KM, Casadei B.
    J Am Coll Cardiol; 2012 Jan 03; 59(1):60-70. PubMed ID: 22192670
    [Abstract] [Full Text] [Related]

  • 6. Clopidogrel provides significantly greater inhibition of platelet activity than aspirin when combined with atorvastatin after coronary artery bypass grafting: a prospective randomized study.
    Tetik S, Ak K, Isbir S, Eksioglu-Demiralp E, Arsan S, Iqbal O, Yardimci T.
    Clin Appl Thromb Hemost; 2010 Apr 03; 16(2):189-98. PubMed ID: 19703819
    [Abstract] [Full Text] [Related]

  • 7. Efficacy and tolerability of atorvastatin/fenofibrate fixed-dose combination tablet compared with atorvastatin and fenofibrate monotherapies in patients with dyslipidemia: a 12-week, multicenter, double-blind, randomized, parallel-group study.
    Davidson MH, Rooney MW, Drucker J, Eugene Griffin H, Oosman S, Beckert M, LCP-AtorFen Investigators.
    Clin Ther; 2009 Dec 03; 31(12):2824-38. PubMed ID: 20110022
    [Abstract] [Full Text] [Related]

  • 8. Neutral effect on markers of heart failure, inflammation, endothelial activation and function, and vagal tone after high-dose HMG-CoA reductase inhibition in non-diabetic patients with non-ischemic cardiomyopathy and average low-density lipoprotein level.
    Bleske BE, Nicklas JM, Bard RL, Brook RD, Gurbel PA, Bliden KP, Rajagopalan S, Pitt B.
    J Am Coll Cardiol; 2006 Jan 17; 47(2):338-41. PubMed ID: 16412857
    [Abstract] [Full Text] [Related]

  • 9. Oxygen free radical release in human failing myocardium is associated with increased activity of rac1-GTPase and represents a target for statin treatment.
    Maack C, Kartes T, Kilter H, Schäfers HJ, Nickenig G, Böhm M, Laufs U.
    Circulation; 2003 Sep 30; 108(13):1567-74. PubMed ID: 12963641
    [Abstract] [Full Text] [Related]

  • 10. High-dose atorvastatin enhances the decline in inflammatory markers in patients with acute coronary syndromes in the MIRACL study.
    Kinlay S, Schwartz GG, Olsson AG, Rifai N, Leslie SJ, Sasiela WJ, Szarek M, Libby P, Ganz P, Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering Study Investigators.
    Circulation; 2003 Sep 30; 108(13):1560-6. PubMed ID: 12975259
    [Abstract] [Full Text] [Related]

  • 11. Effect of intensive lipid lowering, with or without antioxidant vitamins, compared with moderate lipid lowering on myocardial ischemia in patients with stable coronary artery disease: the Vascular Basis for the Treatment of Myocardial Ischemia Study.
    Stone PH, Lloyd-Jones DM, Kinlay S, Frei B, Carlson W, Rubenstein J, Andrews TC, Johnstone M, Sopko G, Cole H, Orav J, Selwyn AP, Creager MA, Vascular Basis Study Group.
    Circulation; 2005 Apr 12; 111(14):1747-55. PubMed ID: 15809368
    [Abstract] [Full Text] [Related]

  • 12. High-dose atorvastatin reduces total plasma levels of oxidized phospholipids and immune complexes present on apolipoprotein B-100 in patients with acute coronary syndromes in the MIRACL trial.
    Tsimikas S, Witztum JL, Miller ER, Sasiela WJ, Szarek M, Olsson AG, Schwartz GG, Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Study Investigators.
    Circulation; 2004 Sep 14; 110(11):1406-12. PubMed ID: 15353498
    [Abstract] [Full Text] [Related]

  • 13. The effect of atorvastatin on heart rate variability and lipoproteins in patients treated with coronary bypass surgery.
    Riahi S, Schmidt EB, Amanavicius N, Karmisholt J, Jensen HS, Christoffersen RP, Niebuhr U, Christensen JH, Toft E.
    Int J Cardiol; 2006 Aug 28; 111(3):436-41. PubMed ID: 16290290
    [Abstract] [Full Text] [Related]

  • 14. Statin therapy improves brachial artery vasodilator function in patients with Type 1 diabetes and microalbuminuria.
    Dogra GK, Watts GF, Chan DC, Stanton K.
    Diabet Med; 2005 Mar 28; 22(3):239-42. PubMed ID: 15717868
    [Abstract] [Full Text] [Related]

  • 15. Randomized trial of atorvastatin for reduction of myocardial damage during coronary intervention: results from the ARMYDA (Atorvastatin for Reduction of MYocardial Damage during Angioplasty) study.
    Pasceri V, Patti G, Nusca A, Pristipino C, Richichi G, Di Sciascio G, ARMYDA Investigators.
    Circulation; 2004 Aug 10; 110(6):674-8. PubMed ID: 15277322
    [Abstract] [Full Text] [Related]

  • 16. The effect of rapid lipid lowering with atorvastatin on autonomic parameters in patients with coronary artery disease.
    Szramka M, Harriss L, Ninnio D, Windebank E, Brack J, Skiba M, Krum H.
    Int J Cardiol; 2007 Apr 25; 117(2):287-91. PubMed ID: 16889854
    [Abstract] [Full Text] [Related]

  • 17. Beneficial effects of atorvastatin on sd LDL and LDL phenotype B in statin-naive patients and patients previously treated with simvastatin or pravastatin.
    Baldassarre S, Scruel O, Deckelbaum RJ, Dupont IE, Ducobu J, Carpentier YA.
    Int J Cardiol; 2005 Oct 10; 104(3):338-45. PubMed ID: 16186066
    [Abstract] [Full Text] [Related]

  • 18. Effect of preoperative atorvastatin therapy on paraoxonase activity and oxidative stress after coronary artery bypass grafting.
    Kurban S, Mehmetoglu I, Ege E.
    Perfusion; 2009 Jul 10; 24(4):271-6. PubMed ID: 19843623
    [Abstract] [Full Text] [Related]

  • 19. Reduction in recurrent cardiovascular events with intensive lipid-lowering statin therapy compared with moderate lipid-lowering statin therapy after acute coronary syndromes from the PROVE IT-TIMI 22 (Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction 22) trial.
    Murphy SA, Cannon CP, Wiviott SD, McCabe CH, Braunwald E.
    J Am Coll Cardiol; 2009 Dec 15; 54(25):2358-62. PubMed ID: 20082923
    [Abstract] [Full Text] [Related]

  • 20. Effect of intensive statin therapy on clinical outcomes among patients undergoing percutaneous coronary intervention for acute coronary syndrome. PCI-PROVE IT: A PROVE IT-TIMI 22 (Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction 22) Substudy.
    Gibson CM, Pride YB, Hochberg CP, Sloan S, Sabatine MS, Cannon CP, TIMI Study Group.
    J Am Coll Cardiol; 2009 Dec 08; 54(24):2290-5. PubMed ID: 19958964
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.